Yang Feng

1.2k total citations · 1 hit paper
18 papers, 805 citations indexed

About

Yang Feng is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Yang Feng has authored 18 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 5 papers in Immunology and 4 papers in Surgery. Recurrent topics in Yang Feng's work include Cancer Immunotherapy and Biomarkers (4 papers), Immune cells in cancer (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Yang Feng is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Immune cells in cancer (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). Yang Feng collaborates with scholars based in China, United States and Philippines. Yang Feng's co-authors include Al B. Benson, Christopher H. Crane, David Cella, Ramesh K. Ramanathan, Joanna M. Brell, Patrick J. Loehrer, Steven R. Alberts, Lynne I. Wagner, Patrick J. Flynn and Higinia R. Cárdenes and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Journal of the American College of Surgeons.

In The Last Decade

Yang Feng

16 papers receiving 795 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

2011 604 citations Patrick J. Loehrer, Yang Feng et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yang Feng China	9	653	287	218	184	177	18	805
Noël Stremsdoerfer France	5	517 0.8×	311 1.1×	190 0.9×	193 1.0×	166 0.9×	7	639
Olugbenga Olowokure United States	14	269 0.4×	156 0.5×	98 0.4×	88 0.5×	106 0.6×	35	513
Michele Basso Italy	18	521 0.8×	251 0.9×	212 1.0×	70 0.4×	150 0.8×	47	839
Feifei Na China	14	166 0.3×	224 0.8×	111 0.5×	55 0.3×	78 0.4×	33	618
Caterina Vivaldi Italy	18	760 1.2×	512 1.8×	403 1.8×	98 0.5×	403 2.3×	101	1.3k
Minsig Choi United States	14	360 0.6×	134 0.5×	104 0.5×	60 0.3×	82 0.5×	28	549
Caio Max S. Rocha Lima United States	14	537 0.8×	253 0.9×	114 0.5×	156 0.8×	102 0.6×	39	735
Julio Astudillo Spain	14	482 0.7×	624 2.2×	149 0.7×	51 0.3×	139 0.8×	28	1.2k
Monica Lencioni Italy	16	446 0.7×	214 0.7×	117 0.5×	137 0.7×	200 1.1×	51	791
Jean Pierre Lotz France	10	366 0.6×	127 0.4×	84 0.4×	66 0.4×	101 0.6×	21	566

Countries citing papers authored by Yang Feng

Since Specialization

Citations

This map shows the geographic impact of Yang Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Feng more than expected).

Fields of papers citing papers by Yang Feng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Feng. The network helps show where Yang Feng may publish in the future.

Co-authorship network of co-authors of Yang Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Feng. A scholar is included among the top collaborators of Yang Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Feng. Yang Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Liu, Zheng, Shaoyi Chen, Jingwei Zhang, et al.. (2025). Engineered circular RNA-based DLL3-targeted CAR-T therapy for small cell lung cancer. Experimental Hematology and Oncology. 14(1). 35–35. 11 indexed citations

Feng, Yang, et al.. (2024). Caucasian validation of downstaging from IIB to IIA in T1N1M0 patients within the 9th edition of the non‐small cell lung cancer tumor‐node‐metastasis staging. Cancer Medicine. 13(14). e70018–e70018. 3 indexed citations

Chen, Yanlei, et al.. (2024). M2-Type Macrophages and Cancer-Associated Fibroblasts Combine to Promote Colorectal Cancer Liver Metastases. OncoTargets and Therapy. Volume 17. 243–260. 3 indexed citations

Feng, Yang, et al.. (2024). Endometrial large cell neuroendocrine carcinoma: A case report and literature review. Gynecologic Oncology Reports. 54. 101429–101429.

Pu, Ke, Jingyuan Gao, Yang Feng, et al.. (2024). Comprehensive evaluation of immunological attributes and immunotherapy responses of positive T cell function regulators in colorectal cancer. BMC Gastroenterology. 24(1). 339–339.

Huang, Qi, Haiming Chen, Dandan Yin, et al.. (2024). Multi-omics analysis reveals NNMT as a master metabolic regulator of metastasis in esophageal squamous cell carcinoma. npj Precision Oncology. 8(1). 24–24. 19 indexed citations

Chen, Yanlei, Yu Gao, Yanping Wang, et al.. (2022). A study on the correlation between M2 macrophages and regulatory T cells in the progression of colorectal cancer. The International Journal of Biological Markers. 37(4). 412–420. 8 indexed citations

Wang, Yanping, Jikun Wang, Chunyu Yang, et al.. (2021). A study of the correlation between M2 macrophages and lymph node metastasis of colorectal carcinoma. World Journal of Surgical Oncology. 19(1). 91–91. 19 indexed citations

Gao, Yu, Yanlei Chen, Jinhao Liu, et al.. (2021). M2-Type Macrophages Induce Tregs Generation by Activating the TGF-β/Smad Signalling Pathway to Promote Colorectal Cancer Development. OncoTargets and Therapy. Volume 14. 5391–5402. 29 indexed citations

10.

Feng, Yang, Hong Liang, Raúl J. Rosenthal, & Steven D. Wexner. (2020). Significant Interaction between Age and Diabetes Mellitus for Colorectal Cancer: Evidence from NHANES Data 1999-2016. Journal of the American College of Surgeons. 231(4). e111–e111. 1 indexed citations

11.

Liu, Jinhao, Jikun Wang, Yang Feng, et al.. (2020). <p>Study of the Relationship Between Serum Amino Acid Metabolism and Lymph Node Metastasis in Patients with Colorectal Cancer</p>. OncoTargets and Therapy. Volume 13. 10287–10296. 10 indexed citations

12.

Liu, Baohua, Yang Feng, Mingli Jiao, et al.. (2019). <p>Cancer prevalence among the rural poverty-stricken population in Northeast China</p>. Cancer Management and Research. Volume 11. 5101–5112. 5 indexed citations

13.

Berlin, Jordan, Yang Feng, Paul J. Catalano, et al.. (2017). An Intergroup Randomized Phase II Study of Bevacizumab or Cetuximab in Combination with Gemcitabine and in Combination with Chemoradiation in Patients with Resected Pancreatic Carcinoma: A Trial of the ECOG-ACRIN Cancer Research Group (E2204). Oncology. 94(1). 39–46. 16 indexed citations

14.

Yi, Li, et al.. (2016). Clinical observation of Gansu Granules combined with lamivudine and adefovir dipivoxil in treatment of hepatitis B cirrhosis.. 31(8). 1209–1212. 1 indexed citations

15.

Landry, Jerome C., Yang Feng, Roshan S. Prabhu, et al.. (2015). Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204. The Oncologist. 20(6). 615–616. 34 indexed citations

16.

Landry, Jerome C., Yang Feng, Steven J. Cohen, et al.. (2013). Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5‐fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204. Cancer. 119(8). 1521–1527. 41 indexed citations

17.

Loehrer, Patrick J., Yang Feng, Higinia R. Cárdenes, et al.. (2011). Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial. Journal of Clinical Oncology. 29(31). 4105–4112. 604 indexed citations breakdown →

18.

Feng, Yang. (2010). SD rats Polysaccharides on growth performance and immune function. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact